278 related articles for article (PubMed ID: 27525643)
21. High-Density Lipoprotein Particles and Torque Teno Virus in Stable Outpatient Kidney Transplant Recipients.
Jonker J; Doorenbos CSE; Kremer D; Gore EJ; Niesters HGM; van Leer-Buter C; Bourgeois P; Connelly MA; Dullaart RPF; Berger SP; Sanders JF; Bakker SJL
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257843
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
23. Torque Teno Virus: any pathological role in liver transplanted patients?
Burra P; Masier A; Boldrin C; Calistri A; Andreoli E; Senzolo M; Zorzi M; Sgarabotto D; Guido M; Cillo U; Canova D; Bendinelli M; Pistello M; Maggi F; Palù G
Transpl Int; 2008 Oct; 21(10):972-9. PubMed ID: 18564988
[TBL] [Abstract][Full Text] [Related]
24. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
25. Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection.
Lichvar AB; Tremblay S; Leino AD; Shields AR; Cardi MA; Abu Jawdeh BG; Govil A; Kremer J; Cuffy M; Paterno F; Diwan T; Brailey P; Girnita A; Alloway RR; Woodle ES
Transplantation; 2020 Nov; 104(11):2403-2414. PubMed ID: 32000256
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients.
Frye BC; Bierbaum S; Falcone V; Köhler TC; Gasplmayr M; Hettich I; Dürk T; Idzko M; Zissel G; Hengel H; Müller-Quernheim J
Transplantation; 2019 Apr; 103(4):815-822. PubMed ID: 30234787
[TBL] [Abstract][Full Text] [Related]
27. Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients-a pilot study.
Uhl P; Heilos A; Bond G; Meyer E; Böhm M; Puchhammer-Stöckl E; Arbeiter K; Müller-Sacherer T; Csaicsich D; Aufricht C; Rusai K
Pediatr Nephrol; 2021 Jan; 36(1):153-162. PubMed ID: 32524259
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of Torque Teno Virus Viral Load Is Associated with Infection and De Novo Donor Specific Antibodies in the First Year after Kidney Transplantation: A Prospective Cohort Study.
Querido S; Martins C; Gomes P; Pessanha MA; Arroz MJ; Adragão T; Casqueiro A; Oliveira R; Costa I; Azinheira J; Paixão P; Weigert A
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515152
[TBL] [Abstract][Full Text] [Related]
29. The Predicting Role of Torque Teno Virus Infection after Renal Transplantation.
Taher NM; Hussein MR; Kadhim HS
Saudi J Kidney Dis Transpl; 2021; 32(4):1054-1064. PubMed ID: 35229805
[TBL] [Abstract][Full Text] [Related]
30. Association of post-transplantation anellovirus viral load with kidney transplant rejection in children.
Eldar-Yedidia Y; Ben-Shalom E; Hillel M; Belostotsky R; Megged O; Freier-Dror Y; Frishberg Y; Schlesinger Y
Pediatr Nephrol; 2022 Aug; 37(8):1905-1914. PubMed ID: 34999988
[TBL] [Abstract][Full Text] [Related]
31. Development of a standardized real time PCR for Torque teno viruses (TTV) viral load detection and quantification: A new tool for immune monitoring.
Kulifaj D; Durgueil-Lariviere B; Meynier F; Munteanu E; Pichon N; Dubé M; Joannes M; Essig M; Hantz S; Barranger C; Alain S
J Clin Virol; 2018 Aug; 105():118-127. PubMed ID: 29957546
[TBL] [Abstract][Full Text] [Related]
32. Torque Teno Virus as a Novel Biomarker Targeting the Efficacy of Immunosuppression After Lung Transplantation.
Jaksch P; Kundi M; Görzer I; Muraközy G; Lambers C; Benazzo A; Hoetzenecker K; Klepetko W; Puchhammer-Stöckl E
J Infect Dis; 2018 Nov; 218(12):1922-1928. PubMed ID: 30053048
[TBL] [Abstract][Full Text] [Related]
33. The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients.
Regele F; Haupenthal F; Doberer K; Görzer I; Kapps S; Strassl R; Bond G
J Med Virol; 2024 Mar; 96(3):e29554. PubMed ID: 38511586
[TBL] [Abstract][Full Text] [Related]
34. Torque Teno Virus (TTV) in Renal Transplant Recipients: Species Diversity and Variability.
Reyes NS; Spezia PG; Jara R; Filippini F; Boccia N; García G; Hermida E; Poletta FA; Pistello M; Laham G; Maggi F; Echavarria M
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543797
[TBL] [Abstract][Full Text] [Related]
35. Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression.
Redondo N; Navarro D; Aguado JM; Fernández-Ruiz M
Transpl Infect Dis; 2022 Apr; 24(2):e13778. PubMed ID: 34933413
[TBL] [Abstract][Full Text] [Related]
36. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation.
Solis M; Velay A; Gantner P; Bausson J; Filipputtu A; Freitag R; Moulin B; Caillard S; Fafi-Kremer S
J Infect; 2019 Jul; 79(1):56-60. PubMed ID: 31100359
[TBL] [Abstract][Full Text] [Related]
37. Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression.
Jaksch P; Görzer I; Puchhammer-Stöckl E; Bond G
Transplantation; 2022 Oct; 106(10):1940-1951. PubMed ID: 35509090
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.
Albert E; Solano C; Pascual T; Torres I; Macera L; Focosi D; Maggi F; Giménez E; Amat P; Navarro D
J Clin Virol; 2017 Sep; 94():22-28. PubMed ID: 28710997
[TBL] [Abstract][Full Text] [Related]
39. The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients.
Imhof C; Messchendorp L; van Baarle D; Gansevoort RT; Van Leer-Buter C; Sanders JF
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005867
[TBL] [Abstract][Full Text] [Related]
40. CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection.
Doberer K; Kläger J; Gualdoni GA; Mayer KA; Eskandary F; Farkash EA; Agis H; Reiter T; Reindl-Schwaighofer R; Wahrmann M; Cohen G; Haslacher H; Bond G; Simonitsch-Klupp I; Halloran PF; Böhmig GA
Transplantation; 2021 Feb; 105(2):451-457. PubMed ID: 32235256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
